Table 1.
Module | Full name | Primary user | Short description |
---|---|---|---|
DCNi | DCN insights | GDD | Provides insights on patient enrollment, quality and cost, and enables comparison across different studies or countries |
FPO | Footprint optimizer | GDO | Enables study enrollment scenario planning and identification of optimal study locations (countries and sites) based on historical data |
RP | Resource planner | GDO | Forecasts resource requirements, such as staffing and time commitment needed, for each clinical study |
ETP | Early trial pricer | GDO | Enables early prediction of clinical trial costs for various scenarios, allowing teams to choose the most suitable one |
SENSE | SENSE | GDD | The “control tower” for Novartis clinical studies, helping to monitor the portfolio of studies and identify any potential risks to timelines or costs |
RC | Resource cockpit | TRD | Visualizes project portfolio across technical units, and enables prediction and optimization of resource allocation (internal and external) |
Nucleus | Nucleus | TRD | Enables design of optimal study drug supply plans and minimizes supply risk |
DYNAMO | Dynamic allocation with machine optimization | Finance | Forecasts total and phased costs for every new (planning) and ongoing (tracking) clinical trial |
GDD, Global Drug Development; GDO, Global Development Operations; TRD, Technical Research and Development.
Most are identified by an acronym. The Primary User is the GDD Line Function that acts as business owner for the solution and typically brings the largest number of users.